Search

everythinglearnresearchcommunity

for

Search:↓

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Peficitinib can turn human fibroblasts into cells that help grow hair.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.